Current Global Status and Future Development of Traditional Chinese Medicine in the Prevention and Treatment of Coronavirus Disease 2019
  
View Full Text  View/Add Comment  Download reader
DOI:10.4103/wjtcm.wjtcm_43_20
KeyWord:Coronavirus disease 2019, coronavirus pneumonia, traditional Chinese medicine, traditional Chinese medicine globalization
           
AuthorInstitution
Ze-Jia Songa a. School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China
Wan Najbah Nik Nabilab a. School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China;b.School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China; Pharmaceutical Services Program, Ministry of Health, Petaling Jaya, Malaysia
Zhi-Chao Xia a. School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China
Hong-Xi Xuac a. School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China;c.Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
Hits: 551
Download times: 694
Abstract:
      Recognizing the potential of globalizing traditional Chinese medicine (TCM) for coronavirus disease 2019 (COVID-19), this review summarizes the current global use of TCM for COVID-19, status of the internationalization of TCM, and strategy on globalizing TCM for COVID-19. COVID-19 is a novel coronavirus disease that has sparked a pandemic in March 2020 affecting over 110 countries. Although researchers have been racing to develop targeted anti-COVID-19 treatment and vaccine, they are still currently unavailable. Thus, in treating patients infected with COVID-19, western medicine mainly recommended symptomatic treatment and monitoring. Existing drugs are used in the context of clinical trials, and the FDA still not yet approved these drugs for COVID-19. On the other hand, TCM proposed herbal treatment for suspected individuals to take within their observation period, as well as for confirmed COVID-19 patients to take during active phase of disease and during recovery. In China, Integrative Chinese-Western Medicine had been used in treating 91.5% of COVID-19 patients and showed its strength in reducing disease severity, shortening recovery time, and lowering the mortality rate. Despite obstacles in globalizing TCM for the treatment of COVID-19, promoting appropriate use of locally registered TCM products may prevent disease in susceptible individuals, improve the quality of life, and assist in the recovery of COVID-19 patients. With increasing global acceptance, TCM may play a more important role in the battle against infectious disease in the future.
Close